Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles

Journal of Drug Targeting

Volumn 22, Issue 5, 2014, Pages 450-459

  Gao, Huile ^a   Yang, Zhi ^a   Zhang, Shuang ^a   Pang, Zhiqing ^a   Jiang, Xinguo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dual targeting delivery system; Internalization; Subcellular fate; Uptake mechanism

Indexed keywords

APTAMER; AS1411 APTAMER AND TGN PEPTIDE NANOPARTICLE; CHLORPROMAZINE; CLATHRIN; COUMARIN; CYTOCHALASIN D; NANOPARTICLE; NOCODAZOLE; UNCLASSIFIED DRUG; AGRO 100; DRUG CARRIER; OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CAVEOLA; CELL ENCAPSULATION; CELL FATE; CELL ORGANELLE; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENDOCYTOSIS; ENDOSOME; GOLGI COMPLEX; INTERNALIZATION; INTRACELLULAR TRANSPORT; LYSOSOME; MITOCHONDRION; MOUSE; NONHUMAN; PARTICLE SIZE; PINOCYTOSIS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BRAIN TUMOR; CELL FRACTIONATION; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; GLIOMA; METABOLISM; PATHOLOGY; SURFACE PROPERTY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG CARRIERS; ENDOCYTOSIS; ENDOTHELIAL CELLS; GLIOMA; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PARTICLE SIZE; PEPTIDES; SUBCELLULAR FRACTIONS; SURFACE PROPERTIES;

EID: 84896488234     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.886038     Document Type: Article

References (41)

1. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
2. Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006; 58:1456-59
3. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653-64
4. Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
5. Agarwal S, Sane R, Oberoi R, et al. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med 2011;13:e17
6. Gao H, Pang Z, Jiang X. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharmaceut Res 2013;30:2485-98
7. Du J, Lu WL, Ying X, et al. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Mol Pharm 2009;6:905-17.
8. Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012;33:5115-23
9. Yan H, Wang L, Wang J, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012;6:410-20
10. Li J, Feng L, Fan L, et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials 2011;32:4943-50
11. Teng Y, Girvan AC, Casson LK, et al. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res 2007;67:10491-500
12. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662-8
13. Dash BC, Rethore G, Monaghan M, et al. The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility. Biomaterials 2010;31:8188-97
14. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008;3: 145-50
15. Mahmoudi M, Azadmanesh K, Shokrgozar MA, et al. Effect of nanoparticles on the cell life cycle. Chem Rev 2011;111:3407-32
16. Bhattacharyya S, Bhattacharya R, Curley S, et al. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci USA 2010;107:14541-6
17. Mickler FM, Mockl L, Ruthardt N, et al. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. Nano Lett 2012;12:3417-23
18. Gao H, Yang Z, Zhang S, et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep 2013;3:2534
19. Mahmoudi M, Lynch I, Ejtehadi MR, et al. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011;111: 5610-37
20. Pang Z, Lu W, Gao H, et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Rel 2008;128:120-7
21. Gao H, Pan S, Yang Z, et al. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 2011; 32:8669-75
22. Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Rel 2005;107:428-48
23. Chang J, Jallouli Y, Kroubi M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by theblood-brain barrier. Int J Pharmaceut 2009;379:285-92
24. Lu W, Sun Q, Wan J, et al. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 2006;66:11878-87
25. Nam HY, Kwon SM, Chung H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Rel 2009;135:259-67
26. Pang Z, Gao H, Yu Y, et al. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Int J Pharmaceut 2011;415:284-92
27. Jiang S, Rhee SW, Gleeson PA, Storrie B. Capacity of the Golgi apparatus for cargo transport prior to complete assembly. Mol Biol Cell 2006;17:4105-17
28. Liu J, Shapiro JI. Endocytosis and signal transduction: basic science update. Biol Res Nurs 2003;5:117-28
29. Xin H, Jiang X, Gu J, et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011;32: 4293-305
30. Hwang DW, Ko HY, Lee JH, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010;51:98-105
31. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004;56: 1649-59
32. Liu Y, Lu W. Recent advances in brain tumor-targeted nano-drug delivery systems. Expert Opin Drug Deliv 2012;9:671-86
33. Pardridge WM. Vector-mediated drug delivery to the brain. Adv Drug Deliv Rev 1999;36:299-321
34. Shieh YA, Yang SJ, Wei MF, Shieh MJ. Aptamer-based tumortargeted drug delivery for photodynamic therapy. ACS Nano 2010; 4:1433-42
35. Guo J, Gao X, Su L, et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011;32:8010-20
36. Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007;59:748-58
37. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Ann Rev Biochem 2009;78:857-902
38. Dos ST, Varela J, Lynch I, et al. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011;6:e24438
39. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 2003; 4:724-38
40. Ozment TR, Goldman MP, Kalbfleisch JH, Williams DL. Soluble glucan is internalized and trafficked to the Golgi apparatus in macrophages via a clathrin mediated, lipid raft regulated mechanism. J Pharmacol Exp Therapeut 2012;342:808-15
41. Reilly MJ, Larsen JD, Sullivan MO. Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus. Mol Pharm 2012;9:1280-90